1. 2020
  2. Systemic Reprogramming of Monocytes in Cancer

    Kiss, M., Caro, A. A., Raes, G. & Laoui, D., 1 Sep 2020, In : Frontiers in Oncology. 10, 12 p., 1399.

    Research output: Contribution to journalArticle

  3. 2019
  4. Development of LAG-3 nanobodies as potent cancer imaging tracers

    Lecocq, Q., Awad, R. M., Zeven, K., De Vlaeminck, Y., de Mey, W., Debie, P., Puttemans, J., Goyvaerts, C., Raes, G., Keyaerts, M., Devoogdt, N. & Breckpot, K., Dec 2019, In : Annals of Oncology. 30

    Research output: Contribution to journalMeeting abstract (Journal)

  5. Theranostics in immuno-oncology using nanobody derivatives

    Lecocq, Q., De Vlaeminck, Y., Hanssens, H., D'Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N. & Breckpot, K., 25 Oct 2019, In : Theranostics. 9, 25, p. 7772-7791 20 p., 10.7150/thno.34941.

    Research output: Contribution to journalScientific review

  6. Human PD-L1 Nanobody For Immuno-PET Imaging: Sites-pecific Radiolabeling Strategies

    Bridoux, J., Broos, K., Lecocq, Q., Crauwels, M., Martin, C., Cleeren, F., Kondrashov, M., Ballet, S., Bormans, G., Schou, M., Elmore, C., Raes, G., Muyldermans, S., Devoogdt, N., Keyaerts, M., Caveliers, V. & Xavier, C., 18 Oct 2019.

    Research output: Unpublished contribution to conferencePoster

Previous 1 2 3 4 5 6 7 8 ...15 Next

ID: 131689